ARK Invest buys $45 million Rocket Lab stake, trims Twist Bioscience and other holdings
AI Summary- ARK Invest reduced several holdings while increasing exposure to Meta Platforms, Rocket Lab and Intellia Therapeutics.
- Rocket Lab purchases totaled approximately $45 million between August 31 and September 8.
- ARK sold 46,015 Twist Bioscience shares through ARKK for about $5.8 million.